Kailera Therapeutics
Biotechnology Research • 
United States • 101-200 Employees
Company overview
| Headquarters | United States |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 101-200 |
| Socials |
Key Contacts at Kailera Therapeutics
Ana Gabriela Bon
Executive Assistant to Chief Technology Officer and Chief Medical Officer
Kailera Therapeutics Email Formats
Kailera Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@kailera.com), used 68.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@kailera.com | 68.7% |
{first initial}.{last name} | j.doe@kailera.com | 31.3% |
About Kailera Therapeutics
Kailera Therapeutics (Kailera) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Kailera’s most advanced program, KAI-9531 (being developed in China as HRS9531), is an injectable GLP-1/GIP receptor dual agonist that demonstrated positive clinical trial results in obesity in China. The Company is also advancing a diversified pipeline leveraging several mechanisms and routes of delivery. Kailera’s mission is to develop next-generation weight management therapies that give people the power to transform their lives and elevate their overall health. The Company is based in Waltham, MA and San Diego, CA. For more information, visit www.kailera.com.
Kailera Therapeutics revenue & valuation
| Annual revenue | $10,700,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $34,300,000 |
| Total funding | $400,000,000 |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Kailera Therapeutics has 75 employees across 13 departments.
Departments
Number of employees
Peru
Saudi Arabia
Hong Kong
Frequently asked questions
4.8
40,000 users
